NCT01725009View on ClinicalTrials.gov

Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Multiple 15-minute intravenous infusions of 1500 mg levetiracetam

Strength, 100 mg/mL; Form, concentrate for solution for infusion; Frequency, twice a day; Duration, 7 days

Trial Locations (1)

Unknown

01, Tokyo

All Listed Sponsors
lead

UCB Japan Co. Ltd.

INDUSTRY

NCT01725009 - Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males | Biotech Hunter | Biotech Hunter